Wells Fargo’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,577
| Closed | -$986 | – | 7804 |
|
|
2023
Q1 | $986 | Sell |
7,577
-651
| -8% | -$132 | ﹤0.01% | 6387 |
|
|
2022
Q4 | $1.35K | Buy |
8,228
+14
| +0.2% | +$6 | ﹤0.01% | 6098 |
|
|
2022
Q3 | $6K | Buy |
8,214
+4,097
| +100% | +$6.04K | ﹤0.01% | 5884 |
|
|
2022
Q2 | $10K | Buy |
4,117
+1,113
| +37% | +$3.09K | ﹤0.01% | 5771 |
|
|
2022
Q1 | $12K | Buy |
3,004
+601
| +25% | +$3.3K | ﹤0.01% | 6221 |
|
|
2021
Q4 | $19K | Buy |
2,403
+103
| +4% | +$1.21K | ﹤0.01% | 6355 |
|
|
2021
Q3 | $45K | Buy |
2,300
+753
| +49% | +$13.2K | ﹤0.01% | 5668 |
|
|
2021
Q2 | $21K | Buy |
1,547
+6
| +0.4% | +$71 | ﹤0.01% | 5887 |
|
|
2021
Q1 | $14K | Buy |
1,541
+1,081
| +235% | +$7.9K | ﹤0.01% | 6257 |
|
|
2020
Q4 | $2K | Buy |
460
+204
| +80% | +$902 | ﹤0.01% | 6302 |
|
|
2020
Q3 | $1K | Buy |
256
+6
| +2% | +$20 | ﹤0.01% | 6256 |
|
|
2020
Q2 | $1K | Hold |
250
| – | – | ﹤0.01% | 6211 |
|
|
2020
Q1 | $0 | Sell |
250
-5,950
| -96% | -$27.2K | ﹤0.01% | 7042 |
|
|
2019
Q4 | $27K | Buy |
6,200
+200
| +3% | +$940 | ﹤0.01% | 5677 |
|
|
2019
Q3 | $31K | Hold |
6,000
| – | – | ﹤0.01% | 5700 |
|
|
2019
Q2 | $43K | Hold |
6,000
| – | – | ﹤0.01% | 5597 |
|
|
2019
Q1 | $32K | Hold |
6,000
| – | – | ﹤0.01% | 5423 |
|
|
2018
Q4 | $9K | Sell |
6,000
-5,000
| -45% | -$17.8K | ﹤0.01% | 5965 |
|
|
2018
Q3 | $45K | Hold |
11,000
| – | – | ﹤0.01% | 5623 |
|
|
2018
Q2 | $43K | Buy |
+11,000
| New | +$44.9K | ﹤0.01% | 5640 |
|
|
2018
Q1 | – | Sell |
-1,302
| Closed | -$9K | – | 6642 |
|
|
2017
Q4 | $9K | Hold |
1,302
| – | – | ﹤0.01% | 5956 |
|
|
2017
Q3 | $8K | Hold |
1,302
| – | – | ﹤0.01% | 5934 |
|
|
2017
Q2 | $8K | Sell |
1,302
-11
| -0.8% | -$80 | ﹤0.01% | 5830 |
|
|
2017
Q1 | $14K | Hold |
1,313
| – | – | ﹤0.01% | 5794 |
|
|
2016
Q4 | $17K | Sell |
1,313
-187
| -12% | -$6.87K | ﹤0.01% | 5669 |
|
|
2016
Q3 | $174K | Buy |
1,500
+1,087
| +263% | +$106K | ﹤0.01% | 4560 |
|
|
2016
Q2 | $33K | Buy |
413
+125
| +43% | +$10.8K | ﹤0.01% | 5343 |
|
|
2016
Q1 | $22K | Hold |
288
| – | – | ﹤0.01% | 5491 |
|
|
2015
Q4 | $26K | Hold |
288
| – | – | ﹤0.01% | 5506 |
|
|
2015
Q3 | $32K | Buy |
288
+125
| +77% | +$14.4K | ﹤0.01% | 5405 |
|
|
2015
Q2 | $16K | Buy |
163
+100
| +159% | +$10.3K | ﹤0.01% | 5679 |
|
|
2015
Q1 | $7K | Hold |
63
| – | – | ﹤0.01% | 5750 |
|
|
2014
Q4 | $6K | Hold |
63
| – | – | ﹤0.01% | 5821 |
|
|
2014
Q3 | $5K | Hold |
63
| – | – | ﹤0.01% | 5826 |
|
|
2014
Q2 | $5K | Buy |
63
+25
| +66% | +$1.94K | ﹤0.01% | 5811 |
|
|
2014
Q1 | $3K | Buy |
+38
| New | +$3.48K | ﹤0.01% | 5649 |
|
Other funds holding PLXP
Wells Fargo's PLXP Position: Q2 2023 in Review
Wells Fargo sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 7,577 shares — an estimated $986 sold.
Wells Fargo first reported a position in PLXP in Q1 2014 and held it in 36 quarters. The position peaked at $174K in Q3 2016. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.
- Wells Fargo reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Wells Fargo sold 7,577 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $986.
- Wells Fargo first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 36 quarters.
- Wells Fargo's PLx Pharma Inc. Common Stock position peaked at $174K in Q3 2016.
- 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.
Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.